© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
320589 |
As an accredited 4-Bromo-2,6-Difluorophenylacetic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2,6-Difluorophenylacetic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
4-Bromo-2,6-difluorophenylacetic acid isn’t exactly an everyday compound. For folks navigating chemical sourcing, new molecule development, or drug discovery, this molecule stands out with its structure and practical flexibility. The model most labs recognize is built around a difluorinated phenyl ring, tweaked further by the addition of both bromine and acetic acid groups. Although it sounds technical, this combination allows for a level of versatility you don’t often see in other phenylacetic acids. For those who spend hours trying to nudge reactivity or selectivity in the lab, small structural changes can drive big differences, and this one really brings something new to the table.
In chemical synthesis, details aren’t just paperwork—they set the ground rules for how a compound performs. 4-Bromo-2,6-difluorophenylacetic acid has a molecular formula of C8H5BrF2O2, and the presence of two fluorine atoms narrows the electronic focus right onto the central ring. A melting point around 100–105°C means it’s solid at room temperature, making it easier to handle than some stickier or faster-melting analogs. Purity often travels above 98%, since even tiny impurities can cause headaches downstream, whether you’re prepping an intermediate for active pharmaceutical ingredient synthesis or running advanced med-chem screens. The white to off-white solid form helps analysts and operators quickly judge the cleanliness and composition of their batches.
Out in the real world, chemists grab onto molecules like this one for what they enable, not just what they look like on paper. In a typical synthesis pipeline, 4-Bromo-2,6-difluorophenylacetic acid’s blend of halogen and fluorine substitutions opens the door to reactions you can’t always achieve with a simpler phenylacetic acid. Having both the bromine and fluorine in specific positions means you can exploit them independently: the bromine site works well for Suzuki, Heck, or other palladium-catalyzed coupling reactions, while the difluorinated ring resists unwanted side reactions and increases stability.
Anyone who’s spent time in medicinal chemistry understands how much a single atom swap can change a drug candidate’s fate. Fluorine, in particular, regularly pops up in high-value drug scaffolds because of its resistance to metabolic breakdown and its effects on target binding. A compound like 4-bromo-2,6-difluorophenylacetic acid gives medicinal chemists a shortcut toward building fluorinated analogs without starting from scratch each time. Instead, you can retrofit this backbone onto different lead series or tweak biological activity by linking new moieties through that reactive bromine handle. In my work on kinase inhibitors, I’ve seen how substituting with difluorophenyl groups often brings cleaner activity profiles than plain phenyl or mono-fluoro structures.
Plenty of phenylacetic acids hit the market, but few offer the combination seen here. Many available versions swap in chlorine or stick with hydrogen on the aromatic ring. These can work for some needs, but they rarely deliver the balance of electron-withdrawing and reactivity that a paired bromine and dual fluorines allow. As someone who’s weighed the pros and cons of several analogs, I see how these tweaks can boost selectivity and cut down on byproducts—both saving precious time and hard-earned research funding.
In multi-step organic synthesis, reproducibility is king. An inconsistent or overly sensitive starting material wrecks countless hours of optimization. The fluorine atoms in this compound act like an insurance policy; they shore up the core of the molecule, so it stands up better under standard conditions. Brominated aromatics bring their own tricks, too: they’re often easier to track and purify due to their characteristic spectral signals, a boon when you’re analyzing complicated mixtures.
Reading through the literature, you might find dozens of citations for 4-bromo-2,6-difluorophenylacetic acid as an intermediate in pharmaceuticals, agrochemicals, and specialty materials. Sometimes, the difference between a promising lead compound and a commercial dud boils down to whether a researcher had access to the right building block during ideation. From my own experience in early discovery labs, having specialty acids like this opens new routes for analog development, lets the team move faster, and sometimes cuts weeks out of a project timeline.
In practice, laboratories lean on this compound’s dual-functionality: the acetic acid group helps in making amides or esters, common motifs in both drug molecules and crop protection agents. The bromine and fluorine pattern brings in potency, stability, and the chance to precisely direct further synthesis. Contract research organizations and academic groups alike gain a shortcut—one that puts more ambitious chemical space within reach.
Not every phenylacetic acid works in complex chemical campaigns. Traditional benzene-based acids can suffer from too much reactivity or, on the flip side, barely any at all. Some analogs, loaded up with other halogens, may skew later steps or introduce regulatory hurdles because of environmental persistence concerns. Out of the available options, 4-bromo-2,6-difluorophenylacetic acid seems to bridge that tricky gap: the fluorine atoms boost metabolic stability, the bromine invites customization, and the acetic acid balance favors downstream functionalizations.
From a practical angle, shelf-stability stands out too. Where some related acids tend to absorb water or degrade under moderate conditions, this one tends to hold up longer on the bench. It travels well between sites, resists unnecessary polymerization, and often surprises people with how reliably it performs in both small-batch and scale-up settings.
Of course, chemists face hurdles with every intermediate, no matter how well-designed. As I’ve seen in my own work, the presence of both bromine and fluorine means some standard purification techniques need adaptation. Overly aggressive reduction or metalation might pull off those valuable halogens, so a good process chemist learns to find a middle ground. Sourcing high-purity versions takes planning, especially if the supply chain stretches between continents.
Another challenge: cost and access. Specialized building blocks often carry a higher price tag, especially if the synthetic route is complex or still under patent. For those of us pushing tight budgets, that sometimes means weighing whether incremental advantages justify the upfront investment. Some teams sidestep high prices by partnering with contract manufacturers capable of efficient, larger-scale synthesis. Open communication with suppliers—and double-checking batch-to-batch analytical data—keeps surprises at bay.
Working with halogenated aromatic acids teaches a few safety lessons the hard way. As with many specialty chemicals, proper lab ventilation matters. The low volatility of 4-bromo-2,6-difluorophenylacetic acid works in its favor, keeping airborne exposure in check. Gloves, goggles, and careful waste handling go a long way, especially since both brominated and fluorinated chemicals can pose extra environmental persistence if mishandled. From what I’ve seen, routine storage in cool, dry conditions plus scrupulous labeling cuts down on mix-ups and loss.
Training junior researchers on the quirks of this molecule—showing that the acid doesn’t react exactly like its plain phenylacetic cousin—builds good lab habits. In scale-up, tight process control over temperature, solvent choice, and work-up ensures clean yields. Tinkering with minor tweaks might seem harmless, but a practiced eye spots how this compound’s unique ring electronics can swing a reaction’s outcome.
Quality matters from the earliest bench experiments all the way to pilot production. Laboratories rely on analytical techniques—NMR, mass spec, HPLC—to confirm purity and identity. The spectral signatures for 4-bromo-2,6-difluorophenylacetic acid serve as a hallmark: sharp aromatic proton peaks offset by distinctive splitting from the fluorines, a lone methylene signal, and good agreement with theoretical mass. Inconsistent samples waste time, so suppliers offering batch-level analytical support earn extra trust.
Even within tightly regulated industries like pharma or fine chemicals, out-of-spec batches do crop up. Purchasing managers and QC staff spot problems fast by comparing against known reference spectra. Mindful sourcing can prevent a compromised batch from stalling months of project work—a fact that’s plagued even the most careful teams at some point.
Modern R&D organizations can’t afford to ignore sustainability. Although fluorinated and brominated compounds sometimes face scrutiny for environmental reasons, responsible sourcing and mindful waste management reduce these risks significantly. In my own experience, partnering with suppliers who uphold strong environmental standards not only avoids regulatory headaches but also helps maintain long-term project momentum. Enforcing in-house waste segregation and supporting solvent recycling builds lasting value for both research groups and communities.
Some chemists see the future in green chemistry innovations—finding routes that generate less hazardous waste even for specialty intermediates like this one. While process development isn’t always fast, incremental progress makes a real difference over the years. Labs that focus on atom economy, minimal solvent use, or reusable catalysts help turn challenging molecules into cleaner, safer products.
Innovation in drug development, specialty materials, and crop protection increasingly depends on access to precision building blocks. 4-Bromo-2,6-difluorophenylacetic acid unlocks new chemical space for med-chem teams scanning for better-targeted therapies, for agrochemical researchers chasing higher selectivity, and for specialty polymer engineers tuning material properties. As more patent filings and publications roll in, access to such versatile intermediates gives an edge to teams seeking both speed and depth in their work.
Bench chemists know that the road from concept to production is messy and detail-driven. Research timelines rarely play out as planned, and winning an edge with the right building blocks sometimes makes or breaks a program. Hybrid academic-industry partnerships see real gains when they can lean on robust, well-documented intermediates. Both big pharma and agile start-ups know the pain of having to redesign workflows just because a critical material’s quality slipped; investing in a better standard up front pays dividends down the line.
Embracing 4-bromo-2,6-difluorophenylacetic acid teaches a few enduring lessons. First, fine-tuned structure means more than theoretical value—it can open new rounds of discovery and sharpen analytical outcomes. Time after time, teams aiming to break ground in drug discovery or specialty chemistry see direct results: higher yields, fewer off-target products, and more rapid pathfinding toward their next lead or scale-up.
Secondly, real-world setbacks push teams to get choosy about suppliers, batch traceability, and in-house analytical rigor. Working with this compound over multiple projects has made it clear that direct relationships with knowledgeable technical support frequently matter more than generic catalog promises. Listening to the signals—a shift in melt point, an unexpected spectral feature, or a yield drop—can turn a nagging suspicion into a life-saving early intervention.
Finally, sustainability and stewardship must play front and center. Responsible handling, efficient synthetic design, and transparent supplier practices all turn what could be a potential headache compound into a cornerstone for innovation. Groups successful with this acid generally treat it not as just another catalog entry, but as a partnership—one where shared responsibility leads to better science, speedier progress, and broader industry trust.
Wider adoption of 4-bromo-2,6-difluorophenylacetic acid tracks directly with broader trends toward smarter, leaner chemical development. Teams focused on first-in-class leads or demanding process optimizations keep gravitating to building blocks that offer both reactivity and a measure of predictability. As patent cliffs loom and regulatory requirements tighten, the appreciation for fully characterized, high-quality intermediates only grows stronger. That’s not hand-waving optimism—it comes from the daily reality of what clears or kills a development pathway.
On the global stage, increased awareness of safety, environmental responsibility, and reproducibility links directly with choosing intermediates that stand up to scrutiny. Teams who build in more robust raw materials face fewer setbacks, lose less time to investigation work, and end up delivering innovations to market far faster. This approach doesn’t just keep chemists happy—it saves effort, slashes costs, and gives decision-makers a sharp, pragmatic reason to revisit their sourcing strategies.
Ensuring the widest benefit from 4-bromo-2,6-difluorophenylacetic acid demands transparency from start to finish. Suppliers that embed batch-level traceability and offer complete analytical packages bring clarity to both R&D purchasers and regulatory agents. Buyers should welcome direct communication, demand proof of analytical data, and push for supplier certifications that go beyond the minimum.
For on-the-ground chemists, regular hands-on training—including the specific quirks of multi-halogenated intermediates—ensures both safety and better yield. Encouraging open discussion about troubleshooting and sharing know-how about purification or stability issues helps laboratories avoid pitfalls and pass best practices down to new generations of researchers.
At the organizational level, integrating environmental management with procurement sends a clear message: innovation and stewardship travel together. By shaping contracts to include environmental provisions, labs can start shifting broader supply chains toward more responsible chemical production.
From hands-on synthesis to strategic project planning, 4-bromo-2,6-difluorophenylacetic acid serves as more than just a reagent; it represents the smarter, more connected way research is heading. With solid structure, reliable specs, and a proven path through both standard and specialized reaction sequences, chemists have good reason to keep reaching for it.
Every researcher who invests the time to understand the full picture—reliability, reactivity, environmental impact, and practical challenges—puts themselves a step ahead. Success in discovery and development hinges on those choices, and the edge provided by outstanding intermediates should never be underestimated. In a field built on details, the right compound at the right time often makes all the difference.
